US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist

22.770
+0.150+0.66%

Close Dec 27 16:00 ET

22.750
-0.020-0.09%

Post 20:01 ET

25.80BMarket Cap-26.79P/E (TTM)

Teva Pharmaceutical Industries Key Stats

Teva Pharmaceutical Industries Q3 2024 Earnings Date

Currency：USDNov 6, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	4.13B	4.33B	+206.96M
Beat Est.	+7.14%	+12.52%	+5.02%
EPS	-<0.01	-0.39	-0.39
Miss Est.	-103.57%	-750.00%	-15500.00%

Analyst Rating

Strong Buy

Dec 28, 2024

Teva Pharmaceutical Industries Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.829B	--
Jan 29, 2025	2024/Q4	-- / 4.122B	--
Nov 6, 2024	2024/Q3	4.332B / 4.125B	--
Jul 31, 2024	2024/Q2	4.164B / 4.045B	--
May 8, 2024	2024/Q1	3.819B / 3.740B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.829B--

Jan 29, 20252024/Q4-- / 4.122B--

Nov 6, 20242024/Q34.332B / 4.125B--

Jul 31, 20242024/Q24.164B / 4.045B--

May 8, 20242024/Q13.819B / 3.740B--

Unlock Free Earnings Estimates

Open Account

Teva Pharmaceutical Industries Earnings Reports

10-Q: Q3 2024 Earnings Report

Nov 6 16:15 ET

8-K: Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS

Nov 6 07:02 ET

10-Q: Q2 2024 Earnings Report

Jul 31 16:11 ET

10-Q: Q1 2024 Earnings Report

May 8 17:14 ET